Moscow, 29th April 2013 – MD Medical Group Investments Plc, Russia’s leading provider of private women’s and children’s healthcare, has completed the acquisition of the IDK Medical Company, a network of women’s and children’s health clinics located in the Russian region of Samara.
The acquisition of 100% of the outstanding share capital of Vitanostra Ltd, operator of IDK, was for USD 16.1 million in cash.
Prior to the deal completion, MD Medical received all required approvals, including approval from the Russian Federal Antimonopoly Service.
Raiffeisen Investment acted as an exclusive sell-side financial advisor to IDK Medical Company.
About Raiffeisen Investment
Raiffeisen Investment Russia, a 50:50 Joint Venture between Raiffeisenbank Russia and Raiffeisen Centrobank is a leading M&A advisor in Central Eastern Europe and Turkey. The guiding principle in our core fields of business Mergers&Acquisitions, Equity Capital Markets (ECM), Privatisations, Structured Transactions, Private Placements and Merchant Banking is to act in the best interests of our clients at all times. We do this by giving impartial advice and by combining top-level industry sector expertise of Raiffeisen Centrobank (Consumer Goods, Agro & Retail, Energy/Utilities, Financial Sponsors, Industrials, Life Sciences, Telecoms Media Technology) with local know-how through our Raiffeisen Investment network with more than 15 Country Offices. Our growing reputation and years of success mean that we have become the advisor of choice for transactions in emerging Europe.
